Page 14 - Acasti Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acasti pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acasti Pharma Today - Breaking & Trending Today

Acasti Pharma (ACST) Announces Resignation of Jean-Marie Canan from Board

Acasti Pharma (ACST) Announces Resignation of Jean-Marie Canan from Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jean Marie John Canan , Jean Marie Canan , Acasti Pharma , Acasti Pharma Inc , Board Of Directors The Company , Announces Resignation , Categories Board Changes ,

Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange

Acasti also confirms no exposure to Silicon Valley Bank or Silvergate Bank
LAVAL, Québec, March 13, 2023 /PRNewswire/ Acasti Pharma Inc. a late-stage, specialty pharma company. | March 13, 2023 ....

United States , Robert Blum , Jan Dalvise , Silicon Valley Bank , Silvergate Bank , Acasti Pharma Inc , Lytham Partners , Securities Exchange , Regulation Services Provider , Venture Exchange , Acasti Pharma , Orphan Drug Designation , Subarachnoid Hemorrhage , Postherpetic Neuralgia , Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Acasti Pharma Inc Stock Exchange , Press Release , Harma Acst Ca00430k8730 ,

Acasti Pharma Recognizes Rare Disease Day

Acasti Pharma Recognizes Rare Disease Day
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Llcrobert Blumtel , Acasti Pharma , Jan Dalvise , Acasti Pharma Inc , Prnewswire Acasti Pharma Inc , Securities Exchange , European Organization For Rare Diseases , Regulation Services Provider , Rare Disease Day , European Organization , Jand Alvise , Orphan Drug Designation , Subarachnoid Hemorrhage , Postherpetic Neuralgia , Looking Statementsstatements , Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Jand Alvisechief Executive Officertel , Lytham Partners ,

Acasti Pharma Recognizes Rare Disease Day

/PRNewswire/ Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical. ....

United States , Robert Blum , Acasti Pharma , Jan Dalvise , Acasti Pharma Inc , Prnewswire Acasti Pharma Inc , Lytham Partners , Securities Exchange , European Organization For Rare Diseases , Regulation Services Provider , Rare Disease Day , European Organization , Jand Alvise , Orphan Drug Designation , Subarachnoid Hemorrhage , Postherpetic Neuralgia , Securities Litigation Reform Act , Securities Act , Securities Exchange Act ,

Acasti Pharma Inc. (NASDAQ:ACST) Q3 2023 Earnings Call Transcript

Company Representatives: Jan D Alvise - President, Chief Executive Officer Brian Ford - Chief Financial Officer Pierre Lemieux - Chief Operating and Scientific Officer, Co-Founder Prashant Kohli - Chief. ....

United States , Oren Livnat , Pierre Lemieux , Leland Gershell , Prashant Kohli , Robert Blum , Brian Ford , Jan Dalvise , Acasti Pharma , Exchange Commission , Acasti Pharma Inc , Acasti Co , Company Representatives , Call Transcript February , Jand Alvise , Chief Executive Officer Brian Ford , Chief Financial Officer Pierre Lemieux , Chief Operating , Scientific Officer , Co Founder Prashant Kohli , Chief Commercial Officer Robert Blum , Acasti Pharma Reports Third Quarter , Fiscal Year , Business Update , Chief Financial Officer , Acasti Co Founder ,